Answers are grounded in this paper and cite their sources.
Study developed a novasomal gel for topical delivery of ketoconazole and hydrocortisone, indicating controlled release efficacy.
Background: Novasomes, modified liposomal vesicles, enable simultaneous encapsulation of hydrophilic and hydrophobic drugs, offering prolonged and targeted drug delivery. Objective: To develop and characterize a novasomal in-situ gel containing ketoconazole (antifungal) and hydrocortisone (anti-inflammatory) for sustained topical delivery. Methods: Novasomes were prepared by the ethanol injection method and incorporated into a thermosensitive in-situ gel of Pluronic F127 (17–25%) and Pluronic F68 (1–5%). The formulations were evaluated for pH, gelation temperature/time, viscosity, spreadability, DSC, TGA, SEM, and in-vitro release using Franz diffusion cells. Results: Formulations exhibited pH 5.5–6.6 and gelation temperatures 22–35℃, enabling sol–gel transition at skin temperature. DSC showed a sharp endothermic peak at 120℃, confirming thermal stability; TGA indicated 10–12 % weight loss between 40–150℃, suggesting low thermal degradation. SEM revealed spherical vesicles (200–400 nm) with uniform surface morphology. In-vitro release reached 89.78 % for ketoconazole and 90.02 % for hydrocortisone within 11 h. Drug release followed zero-order kinetics (R² = 0.93–0.98) and non-Fickian diffusion (n = 0.75–0.89), confirming controlled release behavior. Conclusion: The optimized novasomal in-situ gel demonstrated stable, biocompatible, and controlled topical delivery, highlighting its potential for dual antifungal–anti-inflammatory therapy in dermatological applications.
No takes yet. Share an insight, caveat, or question.
Nadeem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: